Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 13.07.2026 1 AIDS 2 BMC Pediatr 1 BMJ 4 J Infect Dis 3 J Virol 1 Lancet 1 N Engl J Med 1 Pediatrics 7 PLoS One 1 Proc Natl Acad Sci U S A 1 Science 11 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. BOBADILLA R, Tenenbaum TL, Vanpouille C, Wells A, et al
   Impact of influenza and pneumococcal vaccines on inflammatory response during suppressive antiretroviral therapy.
   AIDS. 2026 Jul 7. doi: 10.1097/QAD.0000000000004580.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

2. AYDEMIR O, Korogu M, Ogutlu A, Karabay O, et al
   Sustained seropositivity up to eight years after two-dose inactivated hepatitis A vaccination in Turkish children: a retrospective observational study.
   BMC Pediatr. 2026 Jul 8. doi: 10.1186/s12887-026-07277.
   PubMed         Abstract available
   
   
3. ZABBANI FM, Alzomor O, AlMasary HS
   Vaccination status and severity of pertussis among hospitalized pediatric patients at a tertiary center in Riyadh: an exploratory study.
   BMC Pediatr. 2026 Jul 6. doi: 10.1186/s12887-026-07248.
   PubMed         Abstract available
   
   

   
   BMJ

4. WISE J
   Measles: GP catch-up vaccination campaign starts after two deaths in six months.
   BMJ. 2026;394:e100220.
   PubMed        
   
   

   
   J Infect Dis

5. SKELLINGTON CN, Schmidt K, Schofield C, Ganesan A, et al
   The Effect of Prevaccination Analgesics on Influenza Vaccine Immunogenicity and Effectiveness.
   J Infect Dis. 2026 Jul 10:jiag334. doi: 10.1093.
   PubMed         Abstract available
   
   
6. DESAI M, Jimenez G, Wijewardane P, Lan L, et al
   Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults >/=60 Years of Age.
   J Infect Dis. 2026 Jul 9:jiag350. doi: 10.1093.
   PubMed         Abstract available
   
   
7. 
   Retraction of: Interplay between Tetanus, Diphtheria, Acellular Pertussis Vaccination in Pregnancy and Infant Pneumococcal Vaccination in Shaping Infant Pneumococcal Vaccine Serotype Carriage.
   J Infect Dis. 2026 Jul 8:jiag347. doi: 10.1093.
   PubMed        
   
   
8. DEN HARTOG G, Rochford R
   Can malaria induce loss of vaccine immunity.
   J Infect Dis. 2026 Jul 6:jiag337. doi: 10.1093.
   PubMed        
   
   

   
   J Virol

9. ZHANG Q-Y, Zhang Y, Zhang Z-R, Li Y, et al
   A single-dose chimeric Newcastle disease virus (NDV)/chikungunya virus (CHIKV) is an effective CHIKV vaccine candidate.
   J Virol. 2026 Jul 10:e0056826. doi: 10.1128/jvi.00568.
   PubMed         Abstract available
   
   
10. LAMICHHANE P, Yang L, Santos C, Park H-S, et al
    Live human metapneumovirus vaccine candidates attenuated by temperature sensitivity mutations from human respiratory syncytial virus.
    J Virol. 2026 Jul 6:e0069226. doi: 10.1128/jvi.00692.
    PubMed         Abstract available
    
    
11. CHIU H-J, Carillo KJ, Hsieh LT-H, Lou Y-C, et al
    Structure and functional analyses of vaccinia virus J5 protein reveal distinct determinants for entry-fusion complex assembly and activation.
    J Virol. 2026 Jul 6:e0037926. doi: 10.1128/jvi.00379.
    PubMed         Abstract available
    
    

    
    Lancet

12. WIYSONGE CS, Iwu-Jaja C
    The African Medicines Agency: time for integration with the African Vaccine Regulatory Forum.
    Lancet. 2026;408:121-122.
    PubMed        
    
    

    
    N Engl J Med

13. SEIB KL, Donovan B, Jin F, Thng C, et al
    Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection.
    N Engl J Med. 2026 Jul 8. doi: 10.1056/NEJMoa2516739.
    PubMed         Abstract available
    
    

    
    Pediatrics

14. LEONARD JS, Reinhart K, Lu PJ, Santibanez TA, et al
    Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016-2025.
    Pediatrics. 2026 Jul 6:e2026076453. doi: 10.1542/peds.2026-076453.
    PubMed         Abstract available
    
    

    
    PLoS One

15. AWAD R, Rahal M, Henaine AM, Salameh P, et al
    Correction: Social determinants of vaccine hesitancy among the Lebanese parents: A cross-sectional Study.
    PLoS One. 2026;21:e0353278.
    PubMed         Abstract available
    
    
16. MICHALAKI E, Van Zanten A, Najjar J, Byagathvalli G, et al
    A piezoelectric electroporator (Piezopen) for enhanced "naked" RNA vaccine delivery.
    PLoS One. 2026;21:e0353214.
    PubMed         Abstract available
    
    
17. FUKUDA T, Haruyama R, Tanaka Y, Natori S, et al
    Development of a COVID-19 Vaccination Anxiety Scale to measure COVID-19 vaccine anxiety in Japanese adults.
    PLoS One. 2026;21:e0330146.
    PubMed         Abstract available
    
    
18. LETSOALO MT, Qekwana DN, Mbajiorgu CA, Jaja IF, et al
    Knowledge, attitude, and practices towards rabies: A community survey in selected areas of KwaZulu-Natal Province, South Africa.
    PLoS One. 2026;21:e0352279.
    PubMed         Abstract available
    
    
19. AGHA S, Hassan K, Olusanya TO, Abbas H, et al
    Leveraging social media to mitigate HPV vaccine service disruptions in Abuja, Nigeria.
    PLoS One. 2026;21:e0352986.
    PubMed         Abstract available
    
    
20. HEYDARPOUR R, Mokhtari H, Dehnavi S
    A multi-product, multi-period vaccine supply chain network planning with injection centers and storage conditions.
    PLoS One. 2026;21:e0352121.
    PubMed         Abstract available
    
    
21. LI W, Tan HL, Zhuang CY, Li JY, et al
    Parental knowledge, vaccine hesitancy, and practices regarding seasonal influenza vaccination for preschool-aged children in Shenzhen, China: Insights from a cross-sectional survey.
    PLoS One. 2026;21:e0353478.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

22. ZENG Y, Xu J, Wang J, Xue L, et al
    mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.
    Proc Natl Acad Sci U S A. 2026;123:e2525718123.
    PubMed         Abstract available
    
    

    
    Science

23. LARSON C
    As bird flu threatens, New Zealand vaccinates endangered birds.
    Science. 2026;393:126-127.
    PubMed         Abstract available
    
    

    
    Vaccine

24. WILLIAMS J, Degeling C, Donovan L, Wiley K, et al
    Australians' attitudes to mRNA vaccination in humans and animals: A cross-sectional survey.
    Vaccine. 2026;89:128907.
    PubMed         Abstract available
    
    
25. DE GODOY MENEZES I, Pereira BV, Albuquerque RC, de Almeida SR, et al
    Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis.
    Vaccine. 2026;89:128902.
    PubMed         Abstract available
    
    
26. ZHANG L, Lin T, Wang M, Ma X, et al
    Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].
    Vaccine. 2026 Jul 6:128885. doi: 10.1016/j.vaccine.2026.128885.
    PubMed        
    
    
27. KANDULU CC, Fleming A, O'Mahony A, McHugh S, et al
    Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.
    Vaccine. 2026;89:128909.
    PubMed         Abstract available
    
    
28. AASE A, Herstad TK, Greve-Isdahl M, Tunheim G, et al
    Immunity gaps for several vaccine preventable diseases in Norway.
    Vaccine. 2026;89:128905.
    PubMed         Abstract available
    
    
29. BALDIOTTI ALP, Chi DL
    Caregiver political affiliation is associated with childhood vaccine hesitancy but not fluoride opposition.
    Vaccine. 2026;89:128900.
    PubMed         Abstract available
    
    
30. PETERSON J, Drazan D, Moughan B, Maguire JD, et al
    Erratum to "Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose" [Vaccine 43 (2025) 126469].
    Vaccine. 2026;89:128884.
    PubMed        
    
    
31. GARDNER CL, Brown NN, Brown JL, Morello CS, et al
    Chikungunya virus virus-like particle vaccine (VIMKUNYA) elicits cross-neutralization across CHIKV lineages and against other alphaviruses after just one dose.
    Vaccine. 2026;89:128892.
    PubMed         Abstract available
    
    
32. GONCALVES BP, Olliaro PL, Sullivan SG, Cowling BJ, et al
    Natural direct effects of vaccines and post-vaccination behaviour.
    Vaccine. 2026;89:128888.
    PubMed         Abstract available
    
    
33. MARDANI M, Darazam IA, Moini A, Ebrahimi A, et al
    Immunogenicity and safety of Papilloguard(R) 4, the first quadrivalent HPV vaccine combined with adjuvant system 04, versus Gardasil(R) in healthy 15-25-year-old individuals: a phase III, randomized, double-blind, non-inferiority trial.
    Vaccine. 2026;88:128886.
    PubMed         Abstract available
    
    
34. MCCONEGHY KW, Wilker EH, DeVone F, Skov B, et al
    Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026.
    Vaccine. 2026;88:128882.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum